Put Options

24 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $1.38 Million - $1.61 Million
8,900 Added 16.92%
61,500 $10.5 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $19 Million - $21.7 Million
-119,000 Reduced 69.35%
52,600 $9.58 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $371,520 - $418,419
-2,700 Reduced 1.55%
171,600 $26.6 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $8.43 Million - $9.76 Million
-63,100 Reduced 26.58%
174,300 $26 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $5.51 Million - $6.86 Million
41,600 Added 21.25%
237,400 $32 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $24 Million - $27.6 Million
165,700 Added 550.5%
195,800 $31.2 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $11.5 Million - $13.8 Million
-83,200 Reduced 73.43%
30,100 $4.86 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $7.52 Million - $8.62 Million
-56,000 Reduced 33.08%
113,300 $15.2 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $22.4 Million - $28.5 Million
-163,100 Reduced 49.07%
169,300 $25.9 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $19.1 Million - $23.7 Million
145,000 Added 77.37%
332,400 $53.9 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $2.3 Million - $2.91 Million
21,400 Added 12.89%
187,400 $25.4 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $627,760 - $712,602
-5,900 Reduced 3.43%
166,000 $17.9 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $967,932 - $1.08 Million
9,200 Added 5.65%
171,900 $19.4 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $15.4 Million - $17 Million
-150,880 Reduced 48.12%
162,700 $17.6 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $19.8 Million - $26.7 Million
-245,700 Reduced 43.93%
313,580 $33.6 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $20.8 Million - $24.4 Million
-241,600 Reduced 30.17%
559,280 $49 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $16.1 Million - $21.6 Million
220,080 Added 37.89%
800,880 $78.6 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $2.12 Million - $3.22 Million
-32,900 Reduced 5.36%
580,800 $44.3 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $15.5 Million - $19.4 Million
215,000 Added 53.93%
613,700 $54.3 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $6.24 Million - $7.5 Million
-99,000 Reduced 19.89%
398,700 $29.8 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $27.8 Million - $35.5 Million
422,600 Added 562.72%
497,700 $36.2 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $107,996 - $127,106
-1,400 Reduced 1.83%
75,100 $6.05 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $8.95 Million - $11 Million
-115,000 Reduced 60.05%
76,500 $7.05 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $17 Million - $18.9 Million
191,500 New
191,500 $18.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.